{"id":63676,"date":"2022-06-14T12:27:03","date_gmt":"2022-06-14T10:27:03","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=63676"},"modified":"2023-10-09T15:16:46","modified_gmt":"2023-10-09T15:16:46","slug":"novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/","title":{"rendered":"Novedades en el diagn\u00f3stico y tratamiento del c\u00e1ncer renal en el \u00e1mbito de la farmacia hospitalaria"},"content":{"rendered":"<p>El pasado 26 de mayo el <strong>Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/strong> acogi\u00f3 la formaci\u00f3n <strong>\u201cC\u00e1ncer renal. Actualizaci\u00f3n terap\u00e9utica\u201d<\/strong>, organizada conjuntamente con la <a href=\"http:\/\/www.scfarmclin.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Sociedad Catalana de Farmacia Cl\u00ednica<\/a> y que cont\u00f3 con la colaboraci\u00f3n de<a href=\"https:\/\/www.ipsen.com\/spain\/\" target=\"_blank\" rel=\"noreferrer noopener\">IPSEN<\/a>. Los ponentes fueron <strong>Alejo Rodr\u00edguez<\/strong>, onc\u00f3logo adjunto del Servicio de Oncolog\u00eda M\u00e9dica de la Unidad Funcional de C\u00e1ncer Urol\u00f3gico del Hospital del Marc, <strong>David L\u00f3pez<\/strong>, farmac\u00e9utico adjunto al Servicio de Farmacia en el Instituto Catal\u00e1n de Oncolog\u00eda (ICO), y <strong>Montse Gasol<\/strong> farmac\u00e9utica de la Divisi\u00f3n del Uso Racional del Medicamento y secretaria del Consejo Asesor de la Medicaci\u00f3n Hospitalaria, Gerencia del Medicamento del \u00c1rea Asistencial del Servei Catal\u00e0 de Salut. <strong>David Conde<\/strong>, vocal de Hospitales del COFB, moder\u00f3 la sesi\u00f3n.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"738\" height=\"416\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB-Cancer-Renal-26052022-2.jpg\" alt=\"\" class=\"wp-image-69025\" title=\"El onc\u00f3logo Alejo Rodr\u00edguez al inicio de su presentaci\u00f3n.\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB-Cancer-Renal-26052022-2.jpg 738w, https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB-Cancer-Renal-26052022-2-300x169.jpg 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB-Cancer-Renal-26052022-2-18x10.jpg 18w\" sizes=\"(max-width: 738px) 100vw, 738px\" \/><figcaption class=\"wp-element-caption\">De izquierda a derecha, Alejo Rodr\u00edguez, Montse Gasol, David Conde, y David L\u00f3pez durante la mesa de debate.<\/figcaption><\/figure>\n\n\n\n<p>Dirigida a farmac\u00e9uticos hospitalarios, los objetivos de esta sesi\u00f3n se centraron en conocer las novedades en el diagn\u00f3stico y el tratamiento del c\u00e1ncer renal, explicar las decisiones de posicionamiento y selecci\u00f3n de terapias, y debatir sobre los tratamientos de esta patolog\u00eda. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>El c\u00e1ncer renal y sus factores de riesgo<\/strong><\/h2>\n\n\n\n<p><strong>Alejo Rodr\u00edguez<\/strong>, inici\u00f3 la sesi\u00f3n definiendo el c\u00e1ncer renal y hablando sobre los tratamientos disponibles para hacerle frente. Remarc\u00f3: \u201c<strong>es el c\u00e1ncer m\u00e1s prevalente tanto en hombres como en mujeres.<\/strong> Acostumbra a <strong>aparecer<\/strong> entre los <strong>40 y 60 a\u00f1os<\/strong> y su<strong> incidencia m\u00e1s alta<\/strong> est\u00e1 entre los<strong> 60 y 80 a\u00f1os<\/strong>&#8220;. <\/p>\n\n\n<div class=\"destacat-blog\">\n\n\n<h3 class=\"wp-block-heading\"><strong>La importancia de la detecci\u00f3n precoz en el c\u00e1ncer renal<\/strong><\/h3>\n\n\n\n<p>El <strong>carcinoma de c\u00e9lulas renales (CCR)<\/strong> es el m\u00e1s frecuente de los c\u00e1nceres renales en adultos, representando aproximadamente el <strong>90%<\/strong> de las neoplasias de ri\u00f1\u00f3n. El c\u00e1ncer de ri\u00f1\u00f3n es<strong> asintom\u00e1tico<\/strong> en las <strong>primeras etapas<\/strong>, es por eso que aproximadamente uno <strong>25%-30%<\/strong> de los pacientes presentan<strong> enfermedad metast\u00e1tica<\/strong> en el momento del diagn\u00f3stico.<\/p>\n\n\n\n<p>La <strong>supervivencia de los pacientes con c\u00e1ncer renal ha mejorado en los \u00faltimos a\u00f1os<\/strong> gracias a la disponibilidad de <strong>tratamientos<\/strong> dirigidos a incrementar la <strong>detecci\u00f3n precoz<\/strong> de <strong>tumores de peque\u00f1o volumen<\/strong>. La esperanza de vida de los pacientes con CCR depende del estadio del tumor en el momento del diagn\u00f3stico, por lo que los pacientes con <strong>tumor localizado <\/strong>tienen una <strong>probabilidad de curaci\u00f3n muy alta<\/strong> y una supervivencia, a los 5 a\u00f1os, de entre el 70% y 90%, mientras que s\u00f3lo el 10% de los pacientes con met\u00e1stasis en el momento del diagn\u00f3stico muestran una supervivencia despu\u00e9s de 5 a\u00f1os. <\/p> <\/div>\n\n\n\n<p>En cuanto a los <strong>factores de riesgo<\/strong> causantes de esta enfermedad, el onc\u00f3logo explic\u00f3 que \u201c<strong>no es una patolog\u00eda que tenga un factor de riesgo determinante, es un tumor multifactorial<\/strong>. Hay muchos aspectos que suman, pero no hay ninguno que sea claramente el causante de la enfermedad\u201d. Sin embargo, algunos detonantes pueden ser \u201cel <strong>tabaco<\/strong>, la<strong>exposici\u00f3n laboral<\/strong> en el <strong>cadmio<\/strong>, <strong>amianto <\/strong>y <strong>petr\u00f3leo<\/strong>, <strong>s\u00edndromes metab\u00f3licos como la obesidad<\/strong>, la <strong>hipertensi\u00f3n <\/strong>) <strong>diabetes<\/strong>, y el<strong>historial familiar<\/strong>&#8220;. <\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/06\/COFB-Cancer-Renal-26052022-3.jpg\" alt=\"L'onc\u00f2leg Alejo Rodr\u00edguez a l'inici de la seva presentaci\u00f3.\" class=\"wp-image-63751\" title=\"El onc\u00f3logo Alejo Rodr\u00edguez al inicio de su presentaci\u00f3n.\"\/><figcaption class=\"wp-element-caption\">El onc\u00f3logo Alejo Rodr\u00edguez al inicio de su presentaci\u00f3n.<\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>El ciclo del medicamento y el proceso de comercializaci\u00f3n<\/strong><\/h2>\n\n\n\n<p>Seguidamente, <strong>David L\u00f3pez<\/strong>, habl\u00f3 sobre el <strong>ciclo del medicamento<\/strong> y el <strong>proceso de<\/strong> <strong>comercializaci\u00f3n<\/strong> en la gesti\u00f3n de los tratamientos innovadores del c\u00e1ncer renal en la farmacia hospitalaria.<\/p>\n\n\n\n<p>El farmac\u00e9utico explic\u00f3 que \u201c<strong>detr\u00e1s de la farmacia hay toda una serie de pasos que implican el desarrollo b\u00e1sico del ciclo del medicamento<\/strong>: la investigaci\u00f3n b\u00e1sica o registro del medicamento, la investigaci\u00f3n precl\u00ednica, la investigaci\u00f3n cl\u00ednica, el registro y, por \u00faltimo, el lanzamiento del f\u00e1rmaco\u201d. <\/p>\n\n\n\n<p>En cuanto al <strong>proceso de comercializaci\u00f3n<\/strong>, <strong>L\u00f3pez<\/strong> record\u00f3 los tr\u00e1mites que debe hacer el f\u00e1rmaco hasta llegar a la oficina de farmacia: \u201cinicialmente, el f\u00e1rmaco debe tener una autorizaci\u00f3n. Despu\u00e9s, se notifica en el laboratorio. A partir de aqu\u00ed, es necesario realizar la solicitud de precio y financiaci\u00f3n, la evaluaci\u00f3n de informes t\u00e9cnicos, la negociaci\u00f3n del precio, la fijaci\u00f3n del precio y condiciones de financiaci\u00f3n, la comercializaci\u00f3n, y, por \u00faltimo, la evaluaci\u00f3n del f\u00e1rmaco por parte de diferentes comisiones de las comunidades aut\u00f3nomas\u201d. <\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"566\" height=\"312\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB-Cancer-Renal-26052022-1-1.png\" alt=\"\" class=\"wp-image-69026\" title=\"El onc\u00f3logo Alejo Rodr\u00edguez al inicio de su presentaci\u00f3n.\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB-Cancer-Renal-26052022-1-1.png 566w, https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB-Cancer-Renal-26052022-1-1-300x165.png 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/COFB-Cancer-Renal-26052022-1-1-18x10.png 18w\" sizes=\"(max-width: 566px) 100vw, 566px\" \/><figcaption class=\"wp-element-caption\">El farmac\u00e9utico David L\u00f3pez en un momento de su intervenci\u00f3n.<\/figcaption><\/figure>\n\n\n\n<p>Para concluir la sesi\u00f3n, los ponentes conformaron una <strong>mesa de debate<\/strong> en torno a esta patolog\u00eda, donde se a\u00f1adi\u00f3 <strong>Montse Gasol,<\/strong> farmac\u00e9utica y secretaria del Consejo Asesor de la Medicaci\u00f3n Hospitalaria. Gasol, en relaci\u00f3n con el <strong>mercado farmac\u00e9utico<\/strong>, quiso destacar que \u201c<strong>ha cambiado mucho<\/strong>. Los costes han incrementado, y esto debe tenerse en cuenta a escala estatal. La administraci\u00f3n de la comunidad aut\u00f3noma es quien tiene el presupuesto, ya que en Espa\u00f1a existe un sistema descentralizado, por tanto, <strong>se debe tener una amplia visi\u00f3n del sistema sanitario <\/strong>y las patolog\u00edas a tratar por <strong>preservar el bienestar de la ciudadan\u00eda<\/strong>&#8220;.  <\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"has-text-align-right\"><strong>Actividad organizada conjuntamente con:<\/strong><\/p>\n\n\n\n<div class=\"wp-block-uagb-image uagb-block-16ca5c18 wp-block-uagb-image--layout-default wp-block-uagb-image--effect-static wp-block-uagb-image--align-none\"><figure class=\"wp-block-uagb-image__figure\"><img loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/societat-catalana-farmacia-1.png \" sizes=\"auto, (max-width: 480px) 150px\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/10\/societat-catalana-farmacia-1.png\" alt=\"\" class=\"uag-image-69027\" width=\"630\" height=\"409\" title=\"\"\/><\/figure><\/div>\n\n\n\n<p class=\"has-text-align-right\"><strong>Con la colaboraci\u00f3n:<\/strong><\/p>\n\n\n\n<p> <figure class=\"wp-block-image alignright size-large is-resized\"><a rel=\"noopener\" href=\"https:\/\/www.ipsen.com\/spain\/\" target=\"_blank\"><img decoding=\"async\" width=\"171\" height=\"51\" class=\"wp-image-63696\" style=\"width:171px;height:51px\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/06\/IPSEN_logo_transparent-1024x305.png\" alt=\"\"><\/a><\/figure> <\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>El pasado 26 de mayo el Colegio de Farmac\u00e9uticos de Barcelona acogi\u00f3 la formaci\u00f3n \u201cC\u00e1ncer renal. Actualizaci\u00f3n terap\u00e9utica\u201d, organizada conjuntamente con la Sociedad Catalana de Farmacia Cl\u00ednica y que cont\u00f3 con la colaboraci\u00f3n de IPSEN. Los ponentes fueron Alejo Rodr\u00edguez, onc\u00f3logo adjunto del Servicio de Oncolog\u00eda M\u00e9dica de la [\u2026]<\/p>","protected":false},"author":1,"featured_media":67896,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[748,749,18,19,255,50,52,68,480,70,45,750,76,724,631,751,752,63],"class_list":["post-63676","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-cancer-renal","tag-carcinoma","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-deteccio-precoc","tag-diagnostic","tag-farmaceutic","tag-farmacia","tag-farmacia-hospitalaria","tag-formacio","tag-medicaments","tag-mercat-farmaceutic","tag-oficina-de-farmacia","tag-oncologia","tag-patologia","tag-supervivencia","tag-terapia","tag-tractament"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l&#039;\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir una nova formaci\u00f3 sobre c\u00e0ncer renal.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l&#039;\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir una nova formaci\u00f3 sobre c\u00e0ncer renal.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-14T10:27:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-09T15:16:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"738\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l&#8217;\u00e0mbit de la farm\u00e0cia hospital\u00e0ria\",\"datePublished\":\"2022-06-14T10:27:03+00:00\",\"dateModified\":\"2023-10-09T15:16:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\"},\"wordCount\":902,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg\",\"keywords\":[\"C\u00e0ncer renal\",\"carcinoma\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"detecci\u00f3 preco\u00e7\",\"diagn\u00f2stic\",\"farmac\u00e8utic\",\"Farm\u00e0cia\",\"farm\u00e0cia hospital\u00e0ria\",\"Formaci\u00f3\",\"medicaments\",\"mercat farmac\u00e8utic\",\"Oficina de farm\u00e0cia\",\"oncologia\",\"patologia\",\"superviv\u00e8ncia\",\"ter\u00e0pia\",\"tractament\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\",\"name\":\"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg\",\"datePublished\":\"2022-06-14T10:27:03+00:00\",\"dateModified\":\"2023-10-09T15:16:46+00:00\",\"description\":\"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir una nova formaci\u00f3 sobre c\u00e0ncer renal.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg\",\"width\":738,\"height\":416},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l&#8217;\u00e0mbit de la farm\u00e0cia hospital\u00e0ria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir una nova formaci\u00f3 sobre c\u00e0ncer renal.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/","og_locale":"es_ES","og_type":"article","og_title":"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir una nova formaci\u00f3 sobre c\u00e0ncer renal.","og_url":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2022-06-14T10:27:03+00:00","article_modified_time":"2023-10-09T15:16:46+00:00","og_image":[{"width":738,"height":416,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg","type":"image\/jpeg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l&#8217;\u00e0mbit de la farm\u00e0cia hospital\u00e0ria","datePublished":"2022-06-14T10:27:03+00:00","dateModified":"2023-10-09T15:16:46+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/"},"wordCount":902,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg","keywords":["C\u00e0ncer renal","carcinoma","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","detecci\u00f3 preco\u00e7","diagn\u00f2stic","farmac\u00e8utic","Farm\u00e0cia","farm\u00e0cia hospital\u00e0ria","Formaci\u00f3","medicaments","mercat farmac\u00e8utic","Oficina de farm\u00e0cia","oncologia","patologia","superviv\u00e8ncia","ter\u00e0pia","tractament"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/","url":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/","name":"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg","datePublished":"2022-06-14T10:27:03+00:00","dateModified":"2023-10-09T15:16:46+00:00","description":"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir una nova formaci\u00f3 sobre c\u00e0ncer renal.","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg","width":738,"height":416},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l&#8217;\u00e0mbit de la farm\u00e0cia hospital\u00e0ria"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg",738,416,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg",738,416,false],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg",738,416,false],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg",738,416,false],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg",738,416,false],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg",18,10,false]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir la formaci\u00f3 &#8220;C\u00e0ncer renal. Actualitzaci\u00f3 terap\u00e8utica&#8221;, organitzada conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica i que va comptar amb la col\u00b7laboraci\u00f3 d&#8217;IPSEN. Els ponents van ser Alejo Rodr\u00edguez, onc\u00f2leg adjunt del Servei d&#8217;Oncologia M\u00e8dica de la [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/63676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=63676"}],"version-history":[{"count":4,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/63676\/revisions"}],"predecessor-version":[{"id":69028,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/63676\/revisions\/69028"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media\/67896"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=63676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=63676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=63676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}